Sector: Life Science
Geography: Switzerland
Risk Profile: Core+ / Value add
Date Acquired: 2022
Size: c. 20 000 m2
Volume: c. 80 M€
Asset Class: Equity
The business plan foresees the construction of a brand new property composed of three interconnected buildings for life sciences companies. The property will be located at the foot of the subway station “Vennes” providing access to Lausanne train station in less than 13 minutes and more specifically in the heart of the Biopôle Campus in Lausanne which is Europe's largest life sciences campus, now home to more than 135 companies and research institutes.
Permit: obtained in July 2022. Another permit has been submitted in October 2023 for the interior fit-out works of one of the future tenants.
Construction works: begun in Q4 2022. Asset will be delivered in February 2025 and interior fit-outs in August 2025.
Leasing: a 15-years lease agreement has been signed in June 2023 with a a key player in the Canton's healthcare sector for more than 60% of the net floor area.
Exit: The asset is held within an open-ended vehicle. No exit is currently planned.